🔗 Share this article

Chancellor Reeves has revealed she is preparing "specific measures to deal with cost of living issues" in the forthcoming Budget.

In comments to the BBC, she noted that curbing price rises is a shared task of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Cost Interventions

Reports indicate the administration could take action to reduce utility costs, such as by cutting the current 5% rate of value-added tax applied on energy supplies.

Another possibility is to cut some of the government charges presently added to household expenses.

Fiscal Constraints and Expert Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such actions.

The view from the majority of experts is that Reeves will have to introduce higher taxes or budget cuts in order to meet her self-imposed debt limits.

Previously on the same day, estimates showed there was a £22bn gap for the Treasury chief to fill, which is at the more modest range of projections.

"There's a collective task between the Bank of England and the administration to bear down further on some of the causes of price increases," the Chancellor told reporters in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While much of the focus has been on probable tax rises, the chancellor said the latest information from the OBR had not changed her pledge to election pledges not to raise rates on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and trade issues for the fiscal revenue measures, likely to be focused on those "wealthiest."

International Economic Disputes

Addressing worries about the United Kingdom's commercial links with China she said: "The UK's national security always come first."

Last week's declaration by Chinese authorities to tighten export controls on rare earths and other materials that are crucial for advanced tech production led American leader Donald Trump to suggest an extra 100% tariff on goods from China, raising the prospect of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary described China's action "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to join its battle with China, the Chancellor said she was "very concerned" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the international commerce and creates further obstacles."

"It is my opinion there are areas where we must challenge China, but there are also important prospects to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."

The chancellor also affirmed she was working with international partners "on our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Pricing and Investment

The Chancellor also acknowledged that the price the NHS pays for medicines could increase as a consequence of current discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning investments in the United Kingdom, with some blaming the modest returns they are obtaining.

Recently, the government science advisor said the cost the NHS spends on drugs would must rise to halt businesses and drug research funding leaving the United Kingdom.

Reeves informed the BBC: "It has been observed due to the payment system, that medical research, new drugs have not been provided in the UK in the manner that they are in other European countries."

"We want to ensure that patients getting care from the NHS are can receive the top life-saving medicines in the globe. And so we are examining these issues, and... aiming to secure additional investment into Britain."